Introducing Hidoc Dr KOL Factory The Future Hub for Oncology Leaders Worldwide

New Delhi [India], June 13: In oncology, seamless collaboration is essential; yet, connecting with the right experts across countries remains slow, fragmented, and often challenging. Geographic barriers, unverified profiles, and closed networks create obstacles that delay vital partnerships between oncologists and pharma, slowing research, innovation, and progress in patient care. This is exactly where Hidoc Dr KOL Factory steps in.

Hidoc Dr proudly launches this revolutionary global platform, bringing oncology Key Opinion Leaders (KOLs) from across the world together under one open, verified, and easily searchable roof. Whether you’re in Mumbai, Milan, or Miami, you now have instant access to the sharpest minds in cancer care, right when and where you need them.

 

The vision of Hidoc KOL Factory is to create a centralized, credible platform where pharma companies can easily find and collaborate with top oncologists worldwide. It offers instant access to verified experts, current research, and clinical insights – ensuring no opportunity for collaboration or innovation is missed.

What sets Hidoc KOL Factory apart is that it is an open-source platform; unlike other existing websites, which tend to be secretive and closed off. This transparency fosters trust and promotes wider collaboration across the oncology community.

Already, 254 verified oncology KOLs have been onboarded, with profiles showcasing their specialties, research, clinical achievements, and contributions. Each profile is vetted by Hidoc’s expert medical team, ensuring reliability and relevance. The goal is to expand to 1,000 KOLs globally, creating one of the largest oncology-focused digital networks in the world.

The Hidoc KOL Factory offers numerous benefits to both pharmaceutical companies and oncologists, including:

●All oncology experts are available on one platform, making it easier for pharma companies to find and connect with them globally.

●Pharma companies can view verified, current profiles to follow oncologists’ research and ideas, helping shape effective strategies that match real-world trends.

●Collaboration and communication between pharma and oncologists are smoother, with Hidoc ensuring on-time payments that build strong, trustworthy relationships.

Powered by Hidoc – the largest verified doctor network in India with 1.6 million registered  healthcare professionals worldwide; the Hidoc KOL Factory combines unparalleled scale, credibility, and medical expertise. It’s set to become the go-to platform for oncology collaboration, research dissemination, and pharmaceutical engagement.

More than just a product launch, the Hidoc KOL Factory represents a global movement to transform how oncologists and pharma connect. If you’re an oncologist seeking to expand your global reach or a pharma company wanting direct access to top oncology minds, this platform is built for you.

The future of oncology engagement is global, collaborative, and insight-driven. With KOL Factory, pharma companies can connect seamlessly with leading oncologists worldwide, while experts gain the visibility and reach they deserve. Join the KOL Factory today and be part of this transformative journey.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

chandan healthcare diagnostics franchise network Health healthcare business NABH NABL NSE Emerge pathology radiology

Chandan Healthcare Scales Franchise Network to 500+ Franchises; Targets 1,000 Franchises by FY27-End

Lucknow (Uttar Pradesh) [India], September 23: Chandan Healthcare Limited (NSE – CHANDAN), – an integrated diagnostics company offering pathology and radiology services, has expanded its diagnostic franchise network to 568 franchises within a short span of six months, strengthening its last-mile presence and diagnostic collection network. The Company plans to scale the network to 1,000 […]

Read More
AI healthcare breast cancer screening c-met cdsco clinical trials fda Health lord’s mark medical device thermal imaging

Lord’s Mark Industries Gets Nod for Final Clinical Trials of AI Breast Cancer Screening Device

New Delhi [India], September 23: Lord’s Mark Industries Limited has informed the BSE that its Technical Committee has approved the final clinical trial stage for its AI-powered, radiation-free wearable breast cancer screening device, with trials planned across the USA, Great Britain and Europe. The disclosure was made under Regulation 30 of the SEBI Listing Obligations […]

Read More
abbit dental disease cbct ct imaging gi stasis Health malocclusion pet care rabbit care rabbit health veterinary dentistry

When Rabbits Stop Eating: Looking Beyond the Teeth – The Emerging Role of Cone Beam CT in Rabbit Dental Disease

New Delhi [India], September 21: Rabbits have become increasingly popular companion animals over the last decade, thanks to their gentle temperament, intelligence and affectionate nature. Despite their growing popularity, rabbit health is often misunderstood, particularly when it comes to dental disease. Many owners assume that a rabbit refusing food is suffering from a digestive problem […]

Read More